drugset / Trial / NCT02485431
Food Effect and Bioavailability of Deflazacort Formulations in Healthy Volunteers
RandomizedCrossoverOpen-labelOther
Summary
This is a Phase 1, single-center, single-dose, randomized, 5-period crossover study designed to assess the comparative bioavailability and food effect of deflazacort. A total of 45 subjects will be randomly assigned to receive 1 of 5 treatment sequences. Each dosing sequence will be enrolled in parallel and all subjects will receive all 5 treatments in a crossover fashion.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deflazacort | Other / unclassified | 36 mg | Oral |
Indications
No indication recorded.